Synergistic effect of N3a with HSPs and mTOR inhibitors in lymphoma cells: Summary of the therapeutic scheme followed in our study, with major findings highlighted in bold

Synergistic effect of N3a with HSPs and mTOR inhibitors in lymphoma cells: Summary of the therapeutic scheme followed in our study, with major findings highlighted in bold. Color-coded arrows represent regulation (red: up-, green: down-). The signaling pathways in which PI3K, mTOR, MDM2, p53, and Hsp90 are participating, are in a continue balance of inter- and intra-activation and deactivation towards cellular homeostasis and fitness. Every imbalance in their regulation supports lymphomagenesis, therefore are targets of promising therapeutic strategies. In the present study we use synergistically four inhibitors of these proteins, namely LY294002, Rapa, N3a, 17-AGG, respectively, aiming to suppress lymphoma cell growth
Synergistic effect of N3a with HSPs and mTOR inhibitors in lymphoma cells: Summary of the therapeutic scheme followed in our study, with major findings highlighted in bold

Publication

Interruption of p53-MDM2 Interaction by Nutlin-3a in Human Lymphoma Cell Models Initiates a Cell-Dependent Global Effect on Transcriptome and Proteome Level (2023) Konstantina Psatha, et al. Cancers (Basel). 2023 Aug;15(15). Figure: F8.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates FKBP12 FKBP12 ncbigene_synonym FKBP1A 2280
Homo sapiens Primates FKBP12 FKBP12 ncbigene_synonym FKBP1AP1 2282
Homo sapiens Primates FKBP12 FKBP12 ncbigene_synonym FKBP1AP2 2283
Homo sapiens Primates FKBP12 FKBP12 ncbigene_synonym FKBP1AP3 2284
Homo sapiens Primates FKBP12 FKBP12 ncbigene_synonym FKBP1AP4 2285
Homo sapiens Primates mTOR MTOR ncbigene_symbol MTOR 2475
Homo sapiens Primates HSPs HSP ncbigene_synonym HSP90B2P 7190
Homo sapiens Primates MDM2 MDM2 ncbigene_symbol MDM2 4193
Homo sapiens Primates PI3K PI3K ncbigene_synonym PIK3CA 5290
Homo sapiens Primates PI3K PI3K ncbigene_synonym PIK3CB 5291
Homo sapiens Primates PI3K PI3K ncbigene_synonym PIK3CD 5293
Homo sapiens Primates PI3K PI3K ncbigene_synonym PIK3CG 5294
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R3 8503
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R4 30849
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R5 23533
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R6 146850
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R1 5295
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R2 5296
Homo sapiens Primates p53 P53 ncbigene_synonym TP53 7157
Homo sapiens Primates p53 P53 famplex_relations TP63 8626
Homo sapiens Primates p53 P53 famplex_relations TP73 7161
Homo sapiens Primates HSP90 HSP90 ncbigene_synonym HSP90AA1 3320
Homo sapiens Primates HSP90 HSP90 famplex_relations HSP90B1 7184
Homo sapiens Primates HSP90 HSP90 famplex_relations TRAP1 10131
Homo sapiens Primates HSP90 HSP90 famplex_relations HSP90AB1 3326
Homo sapiens Primates nM NM ncbigene_symbol NM 4827

Chemical mentions

Word Match MeSH Name ChEBI
Rapamycin rapamycin (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone chebi:9168
17-AAG 17-AAG (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-en-1-ylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate chebi:64153
Rapamycin rapamycin (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone chebi:9168
17-AAG 17-AAG (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-en-1-ylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate chebi:64153

Disease mentions

Word Match MeSH Name DOID